✦ LIBER ✦

Cost effectiveness of misoprostol vs. omeprazole in the prevention of NSAID associated gastrointestinal symptoms in high risk patients

✍ Scribed by T.M. Loughney; E.M. Jai; E. Goo; G.J. Dydek; D. Beaudoin; S. Hammond; J.E. Egan; B.H. Yoshinobu

Book ID: 119391758
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 37 KB
Volume: 96
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)03651-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diclofenac/misoprostol Vs. PPI Prophylax

Diclofenac/misoprostol Vs. PPI Prophylaxis in the prevention of NSAID-induced complications: A cost model comparison

✍ Jay L. Goldstein; Beverly D. Yamashita; Leanne R. Larson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Efficacy and Tolerability of Pantoprazol

Efficacy and Tolerability of Pantoprazole Compared with Misoprostol for the Prevention of NSAID-Related Gastrointestinal Lesions and Symptoms in Rheumatic Patients

✍ Stupnicki, T.; Dietrich, K.; González-Carro, P.; Straszak, A.; Terjung, A 📂 Article 📅 2003 🏛 S. Karger AG 🌐 English ⚖ 187 KB

A randomized study of omeprazole compare

A randomized study of omeprazole compared to misoprostol for prevention of recurrent ulcers and ulcer hemorrhage in high risk patients ingesting aspirin or nsaids

✍ Jensen, Dennis M.; Ho, Samuel; Hamamah, Shant; Frankl, Harold; Faigel, Douglas; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Low frequency of upper gastrointestinal

Low frequency of upper gastrointestinal complications in the high risk patient taking low-dose aspirin or NSAIDs and omeprazole

✍ Lanas, Angel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

The cost-effectiveness of misoprostol in

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

✍ Andreas Maetzel; Marcos Bosi Ferraz; Claire Bombardier 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

## Objective: To reexamine the cost-effectiveness of misoprostol, using data from a recently published placebo-controlled trial of misoprostol in > 8,000 patients with rheumatoid arthritis (ra) taking nonsteroidal antiinflammatory drugs (the misoprostol ulcer complications outcome safety assessment

CEB4: THE COST-EFFECTIVENESS OF FIXED-DO

CEB4: THE COST-EFFECTIVENESS OF FIXED-DOSE COMBINATION OF DICLOFENAC AND MISOPROSTOL IN PREVENTION OF NSAID-INDUCED ULCERS IN RHEUMATOID ARTHRITIS PATIENTS IN POLAND

✍ E Orlewska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB